Literature DB >> 29098423

Hypoglycemia Reduction Strategies in the ICU.

Susan Shapiro Braithwaite1,2, Dharmesh B Bavda3, Thaer Idrees3, Faisal Qureshi4, Oluwakemi T Soetan3.   

Abstract

PURPOSE OF REVIEW: We reviewed the strategies associated with hypoglycemia risk reduction among critically ill non-pregnant adult patients. RECENT
FINDINGS: Hypoglycemia in the ICU has been associated with increased mortality in a number of studies. Insulin dosing and glucose monitoring rules, response to impending hypoglycemia, use of computerization, and attention to modifiable factors extrinsic to insulin algorithms may affect the risk for hypoglycemia. Recurring use of intravenous (IV) bolus doses of insulin in insulin-resistant cases may reduce reliance upon higher IV infusion rates. In order to reduce the risk for hypoglycemia in the ICU, caregivers should define responses to interruption of continuous carbohydrate exposure, incorporate transitioning strategies upon initiation and interruption of IV insulin, define modifications of antihyperglycemic therapy in the presence of worsening renal function or chronic kidney disease, and anticipate the effects traceable to other medications and substances. Institutional and system-wide quality improvement efforts should assign priority to hypoglycemia prevention.

Entities:  

Keywords:  Best practices; Critical care; Critical care protocols; Hypoglycemia; Insulin infusion; Insulin protocol

Mesh:

Substances:

Year:  2017        PMID: 29098423     DOI: 10.1007/s11892-017-0963-3

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  100 in total

1.  Management of U-500 insulin users during inpatient admissions within a Veterans Affairs Medical Center.

Authors:  Catherine E Palladino; Mary E Eberly; John T Emmons; Lisa R Tannock
Journal:  Diabetes Res Clin Pract       Date:  2016-02-16       Impact factor: 5.602

2.  U-500 regular insulin use in hospitalized patients.

Authors:  Purnima Rani Tripathy; M Cecilia Lansang
Journal:  Endocr Pract       Date:  2015-01       Impact factor: 3.443

Review 3.  Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2016-11-21       Impact factor: 19.112

4.  Comparison of 70/30 biphasic insulin with glargine/lispro regimen in non-critically ill diabetic patients on continuous enteral nutrition therapy.

Authors:  Elisa Hsia; Stacey A Seggelke; Joanna Gibbs; Neda Rasouli; Boris Draznin
Journal:  Nutr Clin Pract       Date:  2011-12       Impact factor: 3.080

Review 5.  Individualization through standardization: electronic orders for subcutaneous insulin in the hospital.

Authors:  Mary Kennihan; Tatheer Zohra; Radha Devi; Chitra Srinivasan; Josefina Diaz; Bradley S Howard; Susan S Braithwaite
Journal:  Endocr Pract       Date:  2012 Nov-Dec       Impact factor: 3.443

6.  In vivo kinetics of insulin action on peripheral glucose disposal and hepatic glucose output in normal and obese subjects.

Authors:  R Prager; P Wallace; J M Olefsky
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

7.  Improved safety with intravenous insulin therapy for critically ill patients with renal failure.

Authors:  Roland N Dickerson; Allison M Lynch; George O Maish; Martin A Croce; Gayle Minard; Rex O Brown
Journal:  Nutrition       Date:  2013-10-22       Impact factor: 4.008

8.  Variability of insulin sensitivity during the first 4 days of critical illness: implications for tight glycemic control.

Authors:  Christopher G Pretty; Aaron J Le Compte; J Geoffrey Chase; Geoffrey M Shaw; Jean-Charles Preiser; Sophie Penning; Thomas Desaive
Journal:  Ann Intensive Care       Date:  2012-06-15       Impact factor: 6.925

9.  Predisposing Factors for Hypoglycemia and Its Relation With Mortality in Critically Ill Patients Undergoing Insulin Therapy in an Intensive Care Unit.

Authors:  Ata Mahmoodpoor; Hadi Hamishehkar; Mohammadtagi Beigmohammadi; Sarvin Sanaie; Kamran Shadvar; Hassan Soleimanpour; Ahsan Rahimi; Saeed Safari
Journal:  Anesth Pain Med       Date:  2016-01-31

10.  Safety, efficacy and clinical generalization of the STAR protocol: a retrospective analysis.

Authors:  Kent W Stewart; Christopher G Pretty; Hamish Tomlinson; Felicity L Thomas; József Homlok; Szabó Némedi Noémi; Attila Illyés; Geoffrey M Shaw; Balázs Benyó; J Geoffrey Chase
Journal:  Ann Intensive Care       Date:  2016-03-29       Impact factor: 6.925

View more
  3 in total

1.  Impact of prolonged requirement for insulin on 90-day mortality in critically ill patients without previous diabetic treatments: a post hoc analysis of the CONTROLING randomized control trial.

Authors:  François Thouy; Julien Bohé; Bertrand Souweine; Hassane Abidi; Jean-Pierre Quenot; Fabrice Thiollière; Jean Dellamonica; Jean-Charles Preiser; Jean-François Timsit; Vincent Brunot; Amna Klich; Nicholas Sedillot; Xavier Tchenio; Jean-Baptiste Roudaut; Nicolas Mottard; Hervé Hyvernat; Florent Wallet; Pierre-Eric Danin; Julio Badie; Richard Jospe; Jérôme Morel; Ali Mofredj; Abdelhamid Fatah; Jocelyne Drai; Anne Mialon; Ali Ait Hssain; Alexandre Lautrette; Eric Fontaine; Charles-Hervé Vacheron; Delphine Maucort-Boulch; Kada Klouche; Claire Dupuis
Journal:  Crit Care       Date:  2022-05-16       Impact factor: 19.334

Review 2.  Hypoglycemia Prevention by Algorithm Design During Intravenous Insulin Infusion.

Authors:  Susan Shapiro Braithwaite; Lisa P Clark; Thaer Idrees; Faisal Qureshi; Oluwakemi T Soetan
Journal:  Curr Diab Rep       Date:  2018-03-26       Impact factor: 4.810

3.  A continuous intravenous insulin infusion protocol to manage high-dose methylprednisolone-induced hyperglycemia in patients with severe COVID-19.

Authors:  Yoshihito Takahashi; Hiroshi Matsuura; Hisaya Domi; Hitoshi Yamamura
Journal:  Clin Diabetes Endocrinol       Date:  2022-04-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.